AI Verdict
FAF has stronger fundamentals based on our AI analysis.
FATE vs FAF Fundamental Comparison
| Metric | FATE | FAF |
|---|---|---|
| Revenue | $6.6M | $7.5B |
| Net Income | $-136.3M | $621.8M |
| Net Margin | -2,051.1% | 8.3% |
| ROE | -65.8% | 11.3% |
| ROA | -42.7% | 3.8% |
| Current Ratio | 5.79x | N/A |
| Debt/Equity | 0.07x | -0.04x |
| EPS | $-1.15 | $6.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
FATE vs FAF: Frequently Asked Questions
Is FATE or FAF a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), FAF has stronger fundamentals. FATE is rated STRONG SELL (92% confidence) while FAF is rated BUY (78% confidence). This is not investment advice.
How does FATE compare to FAF fundamentally?
FATE THERAPEUTICS INC has ROE of -65.8% vs First American Financial Corp's 11.3%. Net margins are -2,051.1% vs 8.3% respectively.
Which stock pays higher dividends, FATE or FAF?
FATE has a dividend yield of N/A or no dividend while FAF has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in FATE or FAF for long term?
For long-term investing, consider that FATE has STRONG SELL rating with 92% confidence, while FAF has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about FATE vs FAF?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For FATE vs FAF, the AI consensus favors FAF based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.